Home > Healthcare & Medical Devices > Onco-Nutrition and Supplements Market
Onco-Nutrition and Supplements Market size is expected to record a notable CAGR by 2032. Key factors, such as the rising prevalence of cancer and the ease of availability of advanced healthcare infrastructure are driving the market gains.
As per the American Cancer Society, nearly 1.9 million new cancer cases were expected to occur in the United States in 2022. This surging number of cancer patients has prompted the need for oncology nutrition as proper diet provides the ability to counter the disease and endure the treatment's side effects.
The emergence of several certification programs and awareness seminars across the globe to educate cancer patients and physicians on the importance of oncology nutrition will also play an ideal role in the onco-nutrition and supplements market expansion. The Cancer Nutrition Institute, for example, offers evidence-based educational certification and training programs in metabolic, contemporary, creative, outcomes-based, and integrative oncology nutrition treatment.
With the unprecedented strain on health-care systems, the COVID-19 outbreak increased the importance of nutritional oncology for maintaining a proper diet and strengthening the patient's immune system to aid the battle against the novel infection. The higher inclination to appropriate nutrition among cancer patients is making way for new opportunities for the introduction of new onco-nutrition products and supplements in the post-pandemic era.
By cancer type, the onco-nutrition and supplements market share from the head and neck cancer segment is expected to grow significantly due to the increasing relevance of nutrition among persons affected with the condition. It has been estimated that nearly 30% to 50% of head and neck cancer patients are malnourished before the beginning of therapy. The growing need for satisfying nutritional needs among this patient pool to minimize catabolism is likely to drive the product demand.
Based on end-use, the onco-nutrition and supplements industry size from hospitals is set to depict commendable demand through 2032, powered by numerous services offered by hospitals, including medical nutrition treatment, before and post operative patient counseling. Key factors, such as rising cancer incidence, the transition from parenteral to enteral nutrition, and improved clinical research quality on nutritional therapies have all contributed to the market's potential.
Regionally, the onco-nutrition and supplements market in North America is expected to develop rapidly through 2032. One of the key forces accelerating the industry forward is the rising public awareness regarding the early-stage diagnosis and treatment of cancer. For instance, in February 2022, the U.S. government allocated funding of USD 50 million for a childhood cancer data initiative. The 10-year investment aims to share data to facilitate faster progress in the treatment of childhood cancer. With considerable R&D efforts being put forth into cancer treatment, the demand for subsequent onco-nutrition and supplements is likely to upsurge.
The competitive landscape of the onco-nutrition and supplements industry is inclusive of prominent companies such as Abbott, Danone, B. Braun Melsungen AG, Hormel Foods, Global Health Products, Nestle S.A., and others.